|
|
|
| home > white papers > Systems Engineering for Complex Portable Medical Device Development - Phillips-Medisize |
|
|
 WHITE PAPERS |
|
Phillips-Medisize
|
|
Systems Engineering for Complex Portable Medical Device Development
|
|
As the demand for complex, portable medical devices continues to grow,
reducing risk and increasing efficiency during the development of these
products should be paramount. Taking a systems-engineering (SE) approach
to development provides a holistic, organized, and deliberate method
for identifying as well as reducing both patient and business risks
early in the process. Furthermore, it facilitates efficient progression
throughout the entire product development life cycle.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
BioIVT Publishes New Research On the Mechanisms Underlying the C-DILI Assay
BioIVT, a leading provider of research models and services for drug development, today announced its research into the mechanisms involved in cholestatic drug-induced liver injury (DILI) has been published in Applied In Vitro Toxicology.1
More info >> |
|
 |
White Papers |
 |
|
The Impact of Components on Drug Quality and Risk Mitigation
West Pharmaceutical Services, Inc.
Expectations for quality by regulatory agencies are increasing at a very fast pace, especially for prefilled drug delivery formats, thanks to increased focus on reducing risk to patient safety. The trend has resulted in delays for new drug applications, more recalls of marketed products and even drug shortages if the container system and drug contents are suspect for quality issues. The pharmaceutical market is now requiring manufacturers of containers and components to meet new expectations with a quality culture and very high product reliability. The need to bridge the gap and provide superior quality products has been a driver for manufacturing technology investments, more robust control strategies and the introduction of next generation elastomer components.
More info >> |
|
 |
Industry Events |
 |
6th Annual Single Cell Analysis Congress
8-9 November 2018, London, UK
Oxford
Global is proud to present its 6th Annual Single Cell Analysis Congress taking
place on 8-9 November 2018 in London. Part of the Genomics
& Synthetic Biology Series UK, the congress will bring together over 600
end users representing internationally renowned research & academic
institutions, clinical research institutions, healthcare organisations as well
as leading pharmaceutical and biotech companies.
More info >> |
|
|
|
